Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CORRECTION

CORRECTION Framingham Heart Study Data on Females Using Estrogen Supplements During a recent update of data collected from the Tables 1-3 for females using estrogen aged 50-79 Framingham Heart Study, we found some minor er- years are printed below. The other parts of Tables 1 - rors that affect Tables 1-3 of our article (Abbott RD, 3, along with Table 4 and Figures 1-6, are not affect- Garrison RJ, Wilson PWF, Epstein FH, Castelli WP, ed by these changes and remain valid. Feinleib M, LaRue C. Joint distribution of lipoprotein We apologize for this mistake and any incon- cholesterol classes. The Framingham Study. Arte- venience we may have caused the readers of this riosclerosis 1983;3:260-272). The corrected data in journal. Table 1. Mean and Percentlles of High Density Lipoprotein Cholesterol (HDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentlles Aae No. Mean STD 5th 10th 50th 90th 95th (yrs) Females.using estrogen hormones 50-54 63 66.67 18.48 39.00 46.00 64.00 89.00 101.20 40 18.97 31.45 41.10 65.50 85.90 108.00 55-59 65.25 19.43 39.60 67.00 83.20 114.40 60-64 23 65.39 32.00 14 19.29 34.00 39.50 68.50 100.50 111.00 65-69 68.36 7 73.57 26.52 56.00 63.00 131.00 131.00 70-74 56.00 56.00 58.00 81.00 81.00 75-79 3 65.00 13.89 56.00 Table 2. Mean and Percentlles of Low Density Lipoprotein Cholesterol (LDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentiles Age (yrs) No. Mean STD 5th 10th 50th 90th 95th Females using estrogen hormones 50-^54 63 133.87 36.22 89.60 95.60 129.00 175.20 203.20 55-59 40 149.83 39.84 102.00 106.50 136.50 205.10 230.90 60-64 23 140.70 37.66 77.40 89.40 140.00 201.00 208.60 65-69 14 157.36 36.00 121.00 122.00 145.50 218.50 228.00 70-74 7 127.14 24.37 81.00 81.00 129.00 163.00 163.00 75-79 3 126.67 30.01 94.00 94.00 133.00 153.00 153.00 Table 3. Mean and Percentlles of Very Low Density Lipoprotein Cholesterol (VLDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentiles Age (yrs) No. Mean STD 5th 10th 50th 90th 95th Females using estrogen hormones 50-54 63 22.98 16.71 3.20 6.40 20.00 40.80 44.60 55-59 40 25.28 19.70 2.05 5.10 19.00 50.60 71.75 60-64 23 28.26 19.76 3.20 6.80 22.00 62.00 77.60 65-69 14 24.14 10.93 6.00 6.50 25.50 39.50 42.00 70-74 7 27.14 14.04 9.00 9.00 26.00 45.00 45.00 75-79 3 16.00 7.21 8.00 8.00 18.00 22.00 22.00 Robert D. Abbott, Ph.D. Robert J. Garrison, MA. Peter W. F. Wilson, M.D. Epidemiology and Biometry Program Division of Heart and Vascular Diseases National Heart, Lung, and Blood Institute Bethesda, Maryland http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/correction-A7AYWQ1SwM
Copyright
© 1984 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

Framingham Heart Study Data on Females Using Estrogen Supplements During a recent update of data collected from the Tables 1-3 for females using estrogen aged 50-79 Framingham Heart Study, we found some minor er- years are printed below. The other parts of Tables 1 - rors that affect Tables 1-3 of our article (Abbott RD, 3, along with Table 4 and Figures 1-6, are not affect- Garrison RJ, Wilson PWF, Epstein FH, Castelli WP, ed by these changes and remain valid. Feinleib M, LaRue C. Joint distribution of lipoprotein We apologize for this mistake and any incon- cholesterol classes. The Framingham Study. Arte- venience we may have caused the readers of this riosclerosis 1983;3:260-272). The corrected data in journal. Table 1. Mean and Percentlles of High Density Lipoprotein Cholesterol (HDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentlles Aae No. Mean STD 5th 10th 50th 90th 95th (yrs) Females.using estrogen hormones 50-54 63 66.67 18.48 39.00 46.00 64.00 89.00 101.20 40 18.97 31.45 41.10 65.50 85.90 108.00 55-59 65.25 19.43 39.60 67.00 83.20 114.40 60-64 23 65.39 32.00 14 19.29 34.00 39.50 68.50 100.50 111.00 65-69 68.36 7 73.57 26.52 56.00 63.00 131.00 131.00 70-74 56.00 56.00 58.00 81.00 81.00 75-79 3 65.00 13.89 56.00 Table 2. Mean and Percentlles of Low Density Lipoprotein Cholesterol (LDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentiles Age (yrs) No. Mean STD 5th 10th 50th 90th 95th Females using estrogen hormones 50-^54 63 133.87 36.22 89.60 95.60 129.00 175.20 203.20 55-59 40 149.83 39.84 102.00 106.50 136.50 205.10 230.90 60-64 23 140.70 37.66 77.40 89.40 140.00 201.00 208.60 65-69 14 157.36 36.00 121.00 122.00 145.50 218.50 228.00 70-74 7 127.14 24.37 81.00 81.00 129.00 163.00 163.00 75-79 3 126.67 30.01 94.00 94.00 133.00 153.00 153.00 Table 3. Mean and Percentlles of Very Low Density Lipoprotein Cholesterol (VLDL-C) (mg/dl) by Age, Gender, and Hormone Use Percentiles Age (yrs) No. Mean STD 5th 10th 50th 90th 95th Females using estrogen hormones 50-54 63 22.98 16.71 3.20 6.40 20.00 40.80 44.60 55-59 40 25.28 19.70 2.05 5.10 19.00 50.60 71.75 60-64 23 28.26 19.76 3.20 6.80 22.00 62.00 77.60 65-69 14 24.14 10.93 6.00 6.50 25.50 39.50 42.00 70-74 7 27.14 14.04 9.00 9.00 26.00 45.00 45.00 75-79 3 16.00 7.21 8.00 8.00 18.00 22.00 22.00 Robert D. Abbott, Ph.D. Robert J. Garrison, MA. Peter W. F. Wilson, M.D. Epidemiology and Biometry Program Division of Heart and Vascular Diseases National Heart, Lung, and Blood Institute Bethesda, Maryland

Journal

ArteriosclerosisWolters Kluwer Health

Published: Sep 1, 1984

There are no references for this article.